93 related articles for article (PubMed ID: 1557643)
1. Modulation of fluorouracil with recombinant alfa interferon: M. D. Anderson Clinical trial.
Pazdur R; Moore DF; Bready B
Semin Oncol; 1992 Apr; 19(2 Suppl 3):176-9. PubMed ID: 1557643
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials of fluorouracil with alpha-interferon in advanced colorectal carcinomas.
Pazdur R; Bready B; Moore DF
Semin Oncol; 1991 Oct; 18(5 Suppl 7):67-70. PubMed ID: 1948132
[TBL] [Abstract][Full Text] [Related]
3. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
J Clin Oncol; 1995 Apr; 13(4):921-8. PubMed ID: 7707120
[TBL] [Abstract][Full Text] [Related]
4. Fluorouracil and recombinant interferon alfa-2a in advanced gastrointestinal neoplasms.
Pazdur R
Br J Haematol; 1991 Oct; 79 Suppl 1():56-9. PubMed ID: 1931711
[TBL] [Abstract][Full Text] [Related]
5. Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma.
Wadler S; Wiernik PH
Semin Oncol; 1990 Feb; 17(1 Suppl 1):16-21; discussion 38-41. PubMed ID: 2405491
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma.
Wadler S; Goldman M; Lyver A; Wiernik PH
Cancer Res; 1990 Apr; 50(7):2056-9. PubMed ID: 2317795
[TBL] [Abstract][Full Text] [Related]
7. Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.
Greco FA; Figlin R; York M; Einhorn L; Schilsky R; Marshall EM; Buys SS; Froimtchuk MJ; Schuller J; Schuchter L; Buyse M; Ritter L; Man A; Yap AK
J Clin Oncol; 1996 Oct; 14(10):2674-81. PubMed ID: 8874326
[TBL] [Abstract][Full Text] [Related]
8. Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience.
Kemeny N; Younes A
Semin Oncol; 1992 Apr; 19(2 Suppl 3):171-5. PubMed ID: 1557642
[TBL] [Abstract][Full Text] [Related]
9. Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.
Wadler S; Schwartz EL; Goldman M; Lyver A; Rader M; Zimmerman M; Itri L; Weinberg V; Wiernik PH
J Clin Oncol; 1989 Dec; 7(12):1769-75. PubMed ID: 2585018
[TBL] [Abstract][Full Text] [Related]
10. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.
O'Dwyer PJ; Manola J; Valone FH; Ryan LM; Hines JD; Wadler S; Haller DG; Arbuck SG; Weiner LM; Mayer RJ; Benson AB
J Clin Oncol; 2001 May; 19(9):2413-21. PubMed ID: 11331320
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.
Pazdur R; Ajani JA; Patt YZ; Winn R; Jackson D; Shepard B; DuBrow R; Campos L; Quaraishi M; Faintuch J
J Clin Oncol; 1990 Dec; 8(12):2027-31. PubMed ID: 2230894
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Lenk H; Wiener N; Boese-Landgraf J; Schalhorn A
Semin Oncol; 1992 Apr; 19(2 Suppl 4):57-62. PubMed ID: 1553576
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced colorectal cancer with recombinant interferon alpha and fluorouracil: activity in liver metastasis.
Díaz Rubio E; Jimeno J; Camps C; Aranda E; Massuti B; Blanco E; Antón A; Lízón J; González Larriba JL
Cancer Invest; 1992; 10(4):259-64. PubMed ID: 1628224
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
Grem JL; McAtee N; Murphy RF; Balis FM; Steinberg SM; Hamilton JM; Sorensen JM; Sartor O; Kramer BS; Goldstein LJ
J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study.
Wadler S; Lembersky B; Atkins M; Kirkwood J; Petrelli N
J Clin Oncol; 1991 Oct; 9(10):1806-10. PubMed ID: 1919631
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
Wadler S; Atkins M; Karp D; Neuberg D; Haynes H; Dutcher JP
Cancer J Sci Am; 1998; 4(4):261-8. PubMed ID: 9689985
[TBL] [Abstract][Full Text] [Related]
18. A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer.
Villar-Grimalt A; Candel MT; Massuti B; Lizón J; Sánchez B; Frau A; Gorostidi B; Goedkoop R
Br J Cancer; 1999 May; 80(5-6):786-91. PubMed ID: 10360656
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinoma.
Weh HJ; Platz D; Braumann D; Buggisch P; Eckardt N; Schmiegel WH; Drescher S; Kleeberg UR; Müllerleile U; Crone-Munzebrock W
Eur J Cancer; 1992; 28A(11):1820-3. PubMed ID: 1389518
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.
Pazdur R; Ajani JJ; Abbruzzese JL; Belt RJ; Dakhil SR; Dubovsky D; Graham S; Pilat S; Winn R; Levin B
Cancer; 1992 Oct; 70(8):2073-6. PubMed ID: 1394037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]